You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 8, 2025

Details for Patent: 7,465,465


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,465,465
Title:Pharmaceutical formulation comprising lanthanum compounds
Abstract:This invention relates to a chewable lanthanum formulation comprising a pharmaceutically effective amount of a lanthanum compound; and at least one chewable pharmaceutically acceptable excipient. This invention also relates to a pharmaceutical formulation in a tablet or in a powder comprising a pharmaceutically effective amount of a lanthanum compound produced by a process which comprises the steps of: a) powder blending the lanthanum compound and at least one pharmaceutically acceptable excipient in a mixer to form a mixture; or b) powder blending the lanthanum compound and excipients, compressing the resulting combination into a slug material or roller compacting the resulting combination into a strand material, and milling the prepared material into a free flowing mixture; and c) compressing the resulting mixture into a tablet or filing up the resulting mixture in a appropriate container.
Inventor(s): Haslam; Robert Paul (Pewsey, GB), Trespidi; Laura Anna (Pizzighettone, IT), Ferdinando; Josephine Christine (Tadley, GB)
Assignee: Shire Biochem Inc. (Laval, Quebec, CA)
Application Number:10/926,330
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,465,465
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form; Process; Use;
Patent landscape, scope, and claims:

Understanding United States Patent 7,465,465: A Detailed Analysis

Introduction

United States Patent 7,465,465, titled "Pharmaceutical formulation comprising lanthanum compounds," is a significant patent in the pharmaceutical industry, particularly in the treatment of hyperphosphatemia. This article will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Scope of the Patent

The patent focuses on a pharmaceutical formulation that includes a pharmaceutically effective amount of a lanthanum compound. Specifically, it describes a chewable formulation designed to be more patient-friendly, especially for those who have difficulty swallowing traditional tablets or capsules[1][4].

Key Components

  • Lanthanum Compounds: The primary active ingredient is lanthanum, often in the form of lanthanum carbonate, which is used to treat hyperphosphatemia, a condition commonly seen in patients with chronic kidney disease.
  • Chewable Formulation: The patent highlights the development of a chewable tablet or formulation, making it easier for patients to administer the medication.
  • Excipients and Diluents: The formulation includes various excipients such as lactose, mannitol, microcrystalline cellulose, and sucrose, which help in the manufacturing process and improve the palatability of the chewable tablets[1].

Claims of the Patent

The patent includes several claims that define the scope of the invention:

Composition Claims

  • These claims specify the composition of the pharmaceutical formulation, including the amount of lanthanum compounds and the types of excipients used.
  • For example, the formulation may include lanthanum carbonate as the active ingredient, along with diluents like lactose or mannitol, and other excipients to enhance the chewable properties[1].

Formulation Claims

  • These claims describe the process of formulating the chewable tablets, including the methods of mixing, milling, and compressing the ingredients.
  • The patent also covers different forms of the formulation, such as tablets, granules, or powders, designed to be chewable[1].

Dosage Form Claims

  • These claims outline the specific dosage forms of the lanthanum compound, including the strength and dosage regimen.
  • The chewable tablets are designed to be administered in a way that ensures effective absorption of the lanthanum compound[1].

Process Claims

  • These claims detail the manufacturing process, including the steps involved in preparing the formulation, such as milling, mixing, and compressing the ingredients into a chewable form[1].

Patent Landscape Analysis

Importance of Patent Landscape Analysis

Patent landscape analysis is crucial for understanding the competitive and technological landscape of a particular field. It helps in identifying key players, trends, and potential gaps in the market[3].

Identifying Competitors

For the lanthanum compound formulations, patent landscape analysis can identify other companies or research institutions working on similar formulations. This includes analyzing patents held by competitors, such as those related to other treatments for hyperphosphatemia, and understanding their strengths and weaknesses[3].

Defining the Scope of the Search

To conduct a thorough patent landscape analysis, it is essential to define the scope clearly. This involves determining the geographical regions to search, the time frame, and whether to include abandoned or expired patents. For lanthanum compounds, the search would likely focus on pharmaceutical formulations, particularly those related to hyperphosphatemia treatment[3].

Patent Search Strategy

The search strategy should include multiple patent and non-patent sources, such as the United States Patent and Trademark Office (USPTO), the World Intellectual Property Organization (WIPO), and the European Patent Office (EPO) databases. Collaborating with technical and market experts is also crucial to identify relevant keywords, patent class codes, and organizations operating in the field[3].

Categorization and Analysis

The collected data needs to be categorized based on the requirements of the technology. This involves manual reading of the patents to classify them into relevant categories, such as by type of formulation, active ingredients, and manufacturing processes. This categorization helps in identifying gaps, key inventors, filing year trends, and top filing countries[3].

Generating a Comprehensive Report

The final step is to generate a report that includes statistical figures and graphs to make the data easily interpretable. This report should highlight patent trends, market developments, and potential risks and opportunities. For example, it might show the number of patents filed over the years, the geographical distribution of these patents, and the expected expiry dates of key patents[3].

Market Impact and Competitive Landscape

Market Trends

The patent landscape analysis for lanthanum compound formulations reveals market trends such as the increasing demand for patient-friendly formulations, particularly in the treatment of chronic conditions like hyperphosphatemia. It also highlights the competitive landscape, with multiple companies investing in R&D to develop innovative formulations.

Licensing and Collaboration

The analysis can help in identifying potential licensing opportunities and collaborations. For instance, companies with expiring patents may be open to licensing agreements, while those with innovative formulations may seek partnerships to expand their market reach[3].

Litigation and Opposition Activities

Understanding the patent landscape also helps in anticipating and mitigating legal risks. By analyzing opposition activities and litigation trends, companies can better protect their intellectual property and avoid potential legal disputes[3].

Key Takeaways

  • Patient-Friendly Formulations: The patent emphasizes the development of chewable formulations, which is a significant advancement in patient compliance and comfort.
  • Competitive Landscape: Patent landscape analysis is essential for understanding the competitive landscape, identifying key players, and recognizing market trends.
  • Innovation and R&D: The patent landscape highlights the ongoing innovation in pharmaceutical formulations, particularly in the treatment of hyperphosphatemia.
  • Legal and Business Insights: The analysis provides valuable legal, business, and technical insights that can guide IP strategy and inform decision-making.

FAQs

What is the primary focus of United States Patent 7,465,465?

The primary focus of this patent is on a pharmaceutical formulation comprising lanthanum compounds, specifically designed as a chewable formulation for treating hyperphosphatemia.

What are the key components of the formulation described in the patent?

The key components include lanthanum compounds (such as lanthanum carbonate), various excipients like lactose, mannitol, and microcrystalline cellulose, and other ingredients to enhance the chewable properties.

How does patent landscape analysis benefit businesses in the pharmaceutical industry?

Patent landscape analysis helps businesses identify competitors, understand market trends, assess the commercial potential of existing patents, and develop new licensing strategies and product enhancements.

What are the steps involved in conducting a patent landscape analysis?

The steps include defining the scope of the search, devising a patent search strategy, categorizing the collected data, and generating a comprehensive report with statistical figures and graphs.

Why is it important to include statistical figures and graphs in a patent landscape report?

Including statistical figures and graphs makes the data easily interpretable, allowing users to derive critical insights quickly and make informed decisions.

Sources

  1. US7465465B2 - Pharmaceutical formulation comprising lanthanum compounds - Google Patents
  2. Pharmaceutical drugs covered by patent 7,465,465 - Drug Patent Watch
  3. Navigating Technological Domains with Patent Landscape Analysis - Sagacious Research
  4. US7465465B2 - Pharmaceutical formulation comprising lanthanum compounds - Google Patents (German translation)

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 7,465,465

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 7,465,465

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 056609 ⤷  Try for Free
Australia 2004266050 ⤷  Try for Free
Australia 2006313490 ⤷  Try for Free
Austria 460169 ⤷  Try for Free
Austria 9809 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.